Monday Morning Blog

Europe Bursts Onto The Biotech Scene As Grifols’ Phase 2b/3 Plasma Replacement Therapy Works In Alzheimer’s Patients. Buy, Sell Or Hold?

2018-11-15 07:01

sabinurce / Pixabay The News: A blood plasma replacement therapy from Spanish company Grifols SA (Barcelona) reduced cognitive decline by 61% in patients with moderate Alzheimer’s dise… Read More

October Wraps Up Healthcare IPOs With Another Strong Week As 2018 Biotech Explosion Still On Record Pace.

2018-11-13 16:48

geralt / Pixabay The News: The Wall Street Journal reports that the pace of biotech IPOs in on track for a near-record year, although many are riskier due to being in earlier stage… Read More

Blockchain In Healthcare

2018-11-07 06:51

TheDigitalArtist / Pixabay How does this shadowy thing called “blockchain” fit into the healthcare delivery system, if at all? Well, “It’s time to get smart about blo… Read More

Stodgy Johns Hopkins Wants FDA To Clear Psilocybin Mushrooms For Depression. Here’s What You Need To Know (or Recall) About The Differences Between Magic Shrooms And, Say, LSD.

2018-11-01 15:37

ekamelev / Pixabay The News: Researchers from Johns Hopkins University (Baltimore) have recommended that psilocybin, the active compound in hallucinogenic mushrooms, be reclassified for medi… Read More

Atrial Fibrillation Increases Risk Of Dementia By 40%, Swedish Study Shows. Bring On Those Blood Thinners, Say Researchers.

2018-10-30 05:31

sbtlneet / Pixabay The News: New evidence suggests that atrial fibrillation, in which the heart has an irregular beat, is linked to an increased risk of dementia. An irregular heartbeat spee… Read More

Physician Burnout Taking Center Stage; What Patients Should Know As Burnout Percentage Soars.

2018-10-25 02:43

caio_triana / Pixabay The News: Nearly half of medical residents report burnout during their second year of residency, and 1 in 7 report regretting their career choice, according to a prospe… Read More

Allogene Scores Record IPO Despite Global Stock Market Collapse. Plethora Of Other Aspiring Startups Thumb Their Noses At Stock Selloff, Filing For Nascent Offerings And Setting IPO Terms.

2018-10-23 05:01

nattanan23 / Pixabay While biotech’s fortunes hit the skid on Wall Street last week, the sector’s biggest IPO of the year went off without a hitch Thursday, suggesting investors… Read More

Monday Morning Blog

Europe Bursts Onto The Biotech Scene As Grifols’ Phase 2b/3 Plasma Replacement Therapy Works In Alzheimer’s Patients. Buy, Sell Or Hold?

October Wraps Up Healthcare IPOs With Another Strong Week As 2018 Biotech Explosion Still On Record Pace.

Blockchain In Healthcare

Stodgy Johns Hopkins Wants FDA To Clear Psilocybin Mushrooms For Depression. Here’s What You Need To Know (or Recall) About The Differences Between Magic Shrooms And, Say, LSD.

Atrial Fibrillation Increases Risk Of Dementia By 40%, Swedish Study Shows. Bring On Those Blood Thinners, Say Researchers.

Physician Burnout Taking Center Stage; What Patients Should Know As Burnout Percentage Soars.

Allogene Scores Record IPO Despite Global Stock Market Collapse. Plethora Of Other Aspiring Startups Thumb Their Noses At Stock Selloff, Filing For Nascent Offerings And Setting IPO Terms.

Healthcare Stocks Bounce Back Friday After Really Messy Week, But Still Licking Their Wounds From Recent Global Selloff.

Why Galapagos’s Phase 3 Rheumatoid Arthritis Success Is Largely Irrelevant.

UK-based Arecor Targets Vast Artificial Pancreas Market With Fast Insulin And Stable Glucagon. Wait; Artificial What?

Monday Morning Blog

Share the post

Subscribe to Monday Morning

Thank you for your subscription